Quality of life (QoL) in elderly NSCLC patients (pts) treated with nab-paclitaxel/carboplatin (nab-P/C) in the ABOUND.70+ trial

Authors :: Karthik C Konduri
Edward J. Kim
Alexandra Sanford
Daniel Haggstrom
Eric C. Anderson
David Smith
Jonathan H. Goldman
M. Modiano
Jared Weiss
M. Socoteanu
Katayoun I. Amiri
Robert M. Jotte
C. Dahkil
Corey J. Langer
Source :: Annals of Oncology. 28:v488-v489
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Oncology
medicine.medical_specialty
chemistry.chemical_compound
chemistry
business.industry
Internal medicine
medicine
Hematology
business
Carboplatin
Nab-paclitaxel

Tools